1. Home
  2. SGHT vs KWY Comparison

SGHT vs KWY Comparison

Compare SGHT & KWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.51

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Kingsway Corporation Common Stock

KWY

Kingsway Corporation Common Stock

N/A

Current Price

$10.31

Market Cap

293.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SGHT
KWY
Founded
2011
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
293.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
SGHT
KWY
Price
$8.51
$10.31
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
263.8K
56.4K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
$134,996,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.42
52 Week Low
$3.19
$8.41
52 Week High
$9.24
$11.36

Technical Indicators

Market Signals
Indicator
SGHT
KWY
Relative Strength Index (RSI) 73.02 52.39
Support Level $8.00 $9.75
Resistance Level $8.80 $10.20
Average True Range (ATR) 0.37 0.43
MACD -0.04 0.03
Stochastic Oscillator 59.84 34.65

Price Performance

Historical Comparison
SGHT
KWY

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About KWY Kingsway Corporation Common Stock

Kingsway Corp is a U.S.-based company employing the Search Fund model to acquire and build great businesses. The company owns and operates a collection of B2B and B2C services companies that are asset-light, growing, profitable, and that have recurring revenues. It seeks to compound long-term shareholder value on a per share basis via its decentralized management model, its talented team of operators, and its tax-advantaged corporate structure.

Share on Social Networks: